Lessons Learned from Marketed and Investigational Prodrugs
- 13 April 2004
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (10), 2393-2404
- https://doi.org/10.1021/jm0303812
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- AS-924, a Novel Orally Active Bifunctional Prodrug of Ceftizoxime. Synthesis and Relationship between Physicochemical Properties and Oral Absorption.CHEMICAL & PHARMACEUTICAL BULLETIN, 1999
- Adefovir DipivoxilDrugs, 1999
- Pharmacokinetics and Bioavailability of Mycophenolate Mofetil in Healthy Subjects after Single‐Dose Oral and Intravenous AdministrationThe Journal of Clinical Pharmacology, 1996
- Highly water soluble taxol derivatives: 2′-polyethyleneglycol esters as potential prodrugsBioorganic & Medicinal Chemistry Letters, 1994
- Safety, Tolerance and Pharmacokinetics of Intravenous Doses of the Phosphate Ester of 3‐Hydroxymethyl‐5,5‐Diphenylhydantoin: A New Prodrug of PhenytoinThe Journal of Clinical Pharmacology, 1988
- (H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 2. The reaction cascade induced by treatment with acids. Formation of 5H-pyrido[1',2':4,5][1,2,4]thiadiazino[2,3-a]benzimidazol-13-ium salts and their reactions with thiolsThe Journal of Organic Chemistry, 1987
- EsmololDrugs, 1987
- ProdrugsDrugs, 1985
- Acyclovir A Review of its Pharmacodynamic Properties and Therapeutic EfficacyDrugs, 1983
- Die Grundlagen der experimentellen ChemotherapieAngewandte Chemie, 1910